Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.

[1]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[2]  P Zabel,et al.  [Chronic obstructive pulmonary disease (COPD)]. , 2006, Der Internist.

[3]  D. D. Briggs,et al.  Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. , 2005, Pulmonary pharmacology & therapeutics.

[4]  A. Woodcock,et al.  Measuring bronchodilation in COPD clinical trials. , 2005, British journal of clinical pharmacology.

[5]  M. Cazzola,et al.  Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma. , 2005, Pulmonary pharmacology & therapeutics.

[6]  A. Woodcock,et al.  A comparison of lung function methods for assessing dose-response effects of salbutamol. , 2004, British journal of clinical pharmacology.

[7]  F. Dente,et al.  Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics. , 2003, Pulmonary pharmacology & therapeutics.

[8]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[9]  A. Buist.  Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[10]  M. Goldman,et al.  Clinical application of forced oscillation. , 2001, Pulmonary pharmacology & therapeutics.

[11]  W. Hop,et al.  Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.

[12]  M. Littner,et al.  Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[13]  J. V. van Noord,et al.  A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease , 2000 .

[14]  H. Wolf.  Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists , 2000, Scandinavian journal of rheumatology. Supplement.

[15]  P. Calverley,et al.  The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction? , 2000, Thorax.

[16]  G. Verleden,et al.  The effects of 5-HT on cholinergic contraction in human airways in vitro. , 1999, The European respiratory journal.

[17]  L. Sichletidis,et al.  BRONCHODILATORY RESPONSES TO FORMOTEROL, IPRATROPIUM, AND THEIR COMBINATION IN PATIENTS WITH STABLE COPD , 1999, International journal of clinical practice.

[18]  R. Pauwels,et al.  Modulation by 5‐HT1A receptors of the 5‐HT2 receptor‐mediated tachykinin‐induced contraction of the rat trachea in vitro , 1998, British journal of pharmacology.

[19]  A. Morice,et al.  Use of Whole-Body Plethysmography to Compare Bronchodilator Inhaler Efficacy , 1998, Respiration.

[20]  BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease , 1997, Thorax.

[21]  P. Henricks,et al.  Characterization of muscarinic receptors in equine tracheal smooth muscle in vitro. , 1997, The Veterinary quarterly.

[22]  F. Lechin,et al.  Increased levels of free serotonin in plasma of symptomatic asthmatic patients. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  J. Mak,et al.  On muscarinic control of neurogenic mucus secretion in ferret trachea. , 1996, The Journal of physiology.

[24]  J. Z. Zhang,et al.  Mechanisms of 5-hydroxytryptamine-induced contraction of isolated rat intrapulmonary bronchi. , 1995, Pulmonary pharmacology.

[25]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[26]  S. Rennard.  Combination bronchodilator therapy in COPD. , 1995, Chest.

[27]  K. Nishimura,et al.  Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. , 1995, Chest.

[28]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[29]  A. Buist,et al.  In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial , 1994 .

[30]  A. Fryer,et al.  Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function. , 1994, Journal of applied physiology.

[31]  D. O’Donnell,et al.  Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. , 1993, The American review of respiratory disease.

[32]  F. Maesen,et al.  Ba 679 Br, a new long-acting antimuscarinic bronchodilator: a pilot dose-escalation study in COPD. , 1993, The European respiratory journal.

[33]  G. Gleich,et al.  Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. , 1993, The Journal of clinical investigation.

[34]  M. Cazzola,et al.  Acute respiratory and cardiovascular effects of inhaled ketanserin in chronic obstructive pulmonary disease. A comparative study with intravenously administered ketanserin. , 1990, Chest.

[35]  R. Allibone,et al.  Pulmonary endocrine cells in chronic bronchitis and emphysema , 1989, The Journal of pathology.

[36]  H. Boushey.  Role of the Vagus Nerves in Bronchoconstriction in Humans , 1985 .

[37]  P. Barnes,et al.  Autonomic regulation of the airways. , 1984, Annual review of medicine.

[38]  W. Warren,et al.  Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. , 1983, Laboratory investigation; a journal of technical methods and pathology.